Share
CME Group CEO Terrence Duffy confirmed on CNBC’s “Fast Money” on June 17 that the exchange operator will file a lawsuit against the Commodity Futures Trading Commission (CFTC) on June 18, challenging the agency’s approval of perpetual futures contracts.
#NEW @CMEGroup to sue CFTC over the approval of perpetual futures as soon as tomorrow.
Outgoing CEO Terry Duffy speaks to Fast Money exclusively on the lawsuit and his decision to retire. https://t.co/g6Kjz4c5bC
— CNBC's Fast Money (@CNBCFastMoney) June 17, 2026
Duffy argued that the instruments are mischaracterized as swaps under the Dodd-Frank Act rather than as legitimate futures products. He said his board has been preparing the legal action for eight months, predating the CFTC’s approval of Kalshi’s Bitcoin (BTC) perpetual futures by a significant margin in late May.
The CFTC approved Kalshi in late May to begin offering Bitcoin perpetual futures, commonly called perps, which function like traditional futures contracts but have no expiration date. Traders can hold positions indefinitely without rolling into a new contract each month.
Coinbase has also confirmed plans to launch its own perpetual crypto futures following CFTC approval, extending the product category beyond a single platform.
Perpetual futures can carry leverage as high as 50-to-1, meaning small price movements can wipe out a trader’s margin and trigger automatic liquidations. Duffy’s objection centers on two points: whether the product belongs in front of retail investors at all, given its leverage profile, and whether the CFTC’s approval process afforded the products adequate scrutiny. He has characterized the regulator’s review as rushed, arguing it bypassed the traditional full review typically applied to a “novel and complex” financial instrument.
Duffy emphasized that the lawsuit followed eight months of board-level preparation, rather than a reactive response to a single approval. “I didn’t start working on it two weeks ago Friday, when there was quick approval of a perpetual future,” Duffy said, describing the decision as the board’s most serious fiduciary undertaking.
Duffy also dismissed the idea that perpetual futures represent genuine financial innovation. “I’d like to know what the innovation is when it comes to perpetual futures,” he said, arguing the only structural difference from a standard futures contract is the absence of an expiration date. He noted CME holds exclusive licensing agreements with every major benchmark index provider, meaning equity-linked perpetual products would still need to route through CME’s infrastructure regardless of the dispute’s outcome, a commercial leverage point separate from the legal argument.
CFTC Chair Michael Selig defended the agency’s decision in his own CNBC appearance days earlier. “It’s time to approve regulated futures contracts that have no expiration date,” he said. “We’re going to make sure the product’s available, but it’s well regulated here in the U.S.”
Shares of CME Group, Cboe Global Markets, and Intercontinental Exchange, the parent company of the New York Stock Exchange, fell following the CFTC’s approval of perpetual futures, reflecting investor concern that the regulatory green light for Kalshi and Coinbase could pose a long-term competitive threat to incumbent derivatives exchanges.
The lawsuit announcement comes alongside a leadership transition at CME. Duffy, who has led the company for approximately a decade, will step down and become executive chairman, with Lynne Fitzpatrick set to become CME’s first female CEO.
The lawsuit, filed June 18, sets up a direct legal and regulatory confrontation between legacy derivatives infrastructure and the crypto-native platforms the CFTC has authorized to offer perpetual futures domestically.
The outcome will likely determine whether perpetual futures become a durable, CFTC-sanctioned product category for American retail traders or face a prolonged legal challenge that delays or unwinds the rollouts already announced by Kalshi and Coinbase.
Duffy’s exclusive benchmark licensing arrangements remain a separate commercial lever regardless of how the litigation resolves.
Share
preferred on
